Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexketoprofen for Rebound Pain After Interscalene Brachial Plexus Block
NCT07642674Recruiting
- Sponsor
- Eskişehir Osmangazi University
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised trial of dexketoprofen (2 arms), sponsored by Eskişehir Osmangazi University. Primary endpoint: Incidence and Severity of Rebound Pain at 24 hours. Started Jun 2026; status: recruiting.
02
Drugs
dexketoprofen
Beyond the preview
Go deeper on NCT07642674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07642674.